Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
-
Rozebalamin(R) for Injection 25 mg (Mecobalamin) Approved in Japan for Amyotrophic Lateral Sclerosis
-
Form 8.5 (EPT/RI) - Touchstone Exploration Inc.
-
Circus Group Appoints Haomiao Fang as New Vice President of Hardware and Manufacturing, Joining from Nissan and Arrival
-
u-blox Unveils X20, Its New Revolutionary All-Band High-Precision GNSS Platform
-
SRYLED Launches LED Display Screens For Indoor and Outdoor Advertising
-
Anticancer Agent "Tasfygo(R) Tablets 35mg" (Tasurgratinib Succinate) Approved in Japan for Biliary Tract Cancer with FGFR2 Gene Fusions or Rearrangements
-
Transforming Asset Management: ETFORE CEO Discusses Vision, Innovation, and Market Strategy
-
"Captain Tsubasa: Dream Team" Kicks Off a Campaign to Celebrate the 3rd Anniversary of NEXT DREAM - An Original Story by Yoichi Takahashi
-
Q2 Metals Drills 188.6 M Interval of Continuous Spodumene-Pegmatite and Concludes the 2024 Summer Drill Campaign at its Cisco Lithium Property, James Bay Quebec Canada
-
Guardsquare Empowers Teams to Achieve the Highest Level of Mobile App Protection in Less Than a Day
-
UL Solutions in Europe Issues First Certification for 400 kW Electric Vehicle Charger Designed for Fast Charging
-
Global Times: Generation Z connect China and the world digitally: report
-
Logitech Launches MX Creative Console, Redefining Digital Creation and Unleashing Your Creative Potential
-
Blueshift Selected by RCS MediaGroup to Revolutionize Multi-Channel Customer Engagement
-
Blubrry Podcasting Unveils Pod2Vid: Seamlessly Covert Your Audio Podcast to Video
-
Ovarian Cancer Awareness Month with All Access with Andy Garcia
-
Avenue Code Empowers Women in Tech: Exclusive Toronto Event Announced
-
Viewpoint with Dennis Quaid Partners with Templafy on New Episode Exploring the Future of Business Documentation and AI Integration
-
Compliancy Group Releases Texas HB 300 Program
-
New Clarivate Report Reveals Challenges and Trends Shaping IP Operations
-
SINBON Unveils ESG Milestones in Latest Sustainability Report
-
Takeda Receives Approval for FRUZAQLA (fruquintinib) in Japan for the Treatment of Unresectable Advanced or Recurrent Colorectal Cancer
-
Nokia selected by Spark as majority 5G RAN partner in New Zealand
-
Smiths Detection and Riskaware join forces to develop next generation CBRN solution
-
Dgpays and Arcapita Consortium Acquires Majority Stake in NEOPAY from Mashreq
-
Quectel Launches QLM29H Series GNSS Receiver, Combining High-Precision Localization With Easy Integration
-
Nokia and ZCorum collaborate to develop DOCSIS Provisioning Adapter for cable-to-fiber transition
-
HUTCHMED Announces Japan Approval for FRUZAQLA® (fruquintinib) Received by Takeda
-
AlgoTx Announces “Last Patient Last Visit” in International Phase II Trial of ATX01 in Chemotherapy-Induced Peripheral Neuropathy
-
Therabody Announces New Innovations and Limited-Edition Bestsellers Ahead of 2024 Holiday Season
-
Form 8.5 (EPT/RI) - NewRiver REIT Plc
-
Form 8.5 (EPT/RI) - Trinity Exploration & Production Plc
-
Groupe Casino: Changes in governance at Monoprix and Naturalia
-
South Korea: TotalEnergies Will Supply 200,000 Tons Per Year of LNG to HD Hyundai Chemical until 2033
-
Together for Sustainability: pester pac automation and Solutum Offer New Environmentally Friendly Packaging Solution
-
Share buybacks in Spar Nord Bank – transactions in week 38
-
The 6th Grand Canal Culture and Tourism Expo: From Jiangsu to the World, Through the History Into the Future
-
Second Well Delineates Heisenberg, Confirms Size of Discovery
-
Regnology Announces the 31st Annual RegTech Convention on November 18-21
-
Llama Group SA: Winamp Opens the Legacy Player Code and Delivers the Latest Features of Winamp for Creators.
-
Terranet reaches strategic milestone - achieves autonomous braking
-
Gaming Innovation Group: Ex date
-
Invitation to presentation of Essity's interim report for quarter 3, 2024
-
"BLEACH Soul Puzzle" Launches Today on September 24 as the First Puzzle Game Based on the BLEACH TV Animation Series
-
Nxera Pharma Receives Approval of QUVIVIQ (daridorexant) 25 and 50 mg in Japan for the Treatment of Insomnia
-
Nxera Pharma Receives Approval of QUVIVIQ (daridorexant) 25 and 50 mg in Japan for the Treatment of Insomnia
-
Japan's Ministry of Health, Labour and Welfare Approves PADCEV™ (enfortumab vedotin) with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Radically Unresectable Urothelial Carcinoma
-
Litchfield Hills Research raises its buy recommendation for Virtualware to €12 per share
-
Selvita reports growing sales in Q2 and Q3, and projects increased profitability in H2 2024
